Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
PRNewswire - November 12, 1999
"We believe the hep C infection to already be at epidemic proportions in California. There is still no vaccine to protect us from this virus," said Kathy Barberich, speaking on behalf of the California Hepatitis C Coalition and lifestyle columnist for the Fresno Bee. "We must protect ourselves through education and screening. We need to do it on a statewide level. If infected individuals are identified, they can then take steps to retain their health, stop the spread of the virus and seek treatment."
The estimates for infection prevalence come from a CDC estimate that 1.8% of the general population is infected with the hepatitis C virus (HCV). However, studies indicate that minority groups are more at risk for hepatitis C. According to John Vierling, M.D., F.A.C.P., Cedars-Sinai Medical Center, California's diverse population may mean California exceeds this national average. Because of a lack of funding within DHS, California does not have statistics available to confirm or deny this assertion.
"We have been unable to find any widespread effort on the part of the Department of Health Services to warn citizens about the virus or investigate the prevalence of the disease," said Phyllis Borchardt, Director of the San Diego Chapter of the American Liver Foundation, a California Hepatitis C Coalition member organization.
The California Department of Corrections appears similarly unprepared to deal with the threat of this virus. Although, a 1994 report from the DHS, Office of AIDS, found a 40% infection rate for hep C in the California prisons, there has been no plan conceived or action taken to stop the spread of the virus within the prison system. In fact, the Wall Street Journal reported in 1997 that the department returned more than $1.8 million to the California general fund. The funds had been earmarked for education and health screening.
"To date, there does not appear to be any plan to act on this menace. We know that hep C is running rampant in our prisons and, with the tight living conditions, spreading the virus is an unavoidable fact rather than just a possibility. This is a dangerous situation for prisoners, corrections staff and the public as these infected prisoners are released to the street on parole. The California Correctional Peace Officers Association (CCPOA) is urging the Department of Corrections to act on this issue," said Jeff Thompson, CCPOA, a California Hepatitis C Coalition member organization.
"We were disappointed that the Department of Corrections chose not to attend the interim hearing," said Borchardt. "Their absence from this hearing indicates to me that hep C is not a priority for them. If that is the case, it is reprehensible. Corrections has the opportunity to make a big impact on the virus because of the high (40%) infection rate in the system and a target group that is easy to reach to educate. I'd like the opportunity to ask them why they are not making that kind of effort."
Four times more people are infected by HCV than are infected by HIV, according to the Centers for Disease Control (CDC). Hepatitis C infects its victims and lives largely undetected in the body for 20 to 30 years. It is generally discovered after it has caused severe damage to the liver. The disease is often called "The Silent Killer."
Individuals who received a blood transfusion before 1992, have used intravenous drugs, inhaled cocaine, received a tissue or organ donation, or are health care workers or military veterans, are at risk and should consult their physicians about being screened for hep C.
Table 1: Chart based on Centers for Disease Control (CDC)
| estimates of 1.8% of population infected with HCV. |
|---|
| STATE POPULATION PREVALENCE RATE |
| California 32,268,000 680,824 |
| Texas 19,439,000 349,902 |
| New York 18,137,000 326,466 |
| Florida 14,654,000 263,772 |
| Pennsylvania 12,020,000 216,360 |
| Illinois 11,896,000 214,128 |
| Ohio 11,186,000 201,348 |
| Michigan 9,774,000 175,932 |
| New Jersey 8,053,000 144,954 |
| Georgia 7,486,000 134,748 |
| North Carolina 7,425,000 133,650 |
| Virginia 6,734,000 121,212 |
| Massachusetts 6,118,000 110,124 |
| Indiana 5,864,000 105,552 |
| Washington 5,610,000 100,980 |
| Missouri 5,402,000 97,236 |
| Tennessee 5,368,000 96,624 |
| Wisconsin 5,170,000 93,060 |
| Maryland 5,094,000 91,692 |
| Minnesota 4,686,000 84,348 |
| Arizona 4,555,000 81,990 |
| Louisiana 4,352,000 78,336 |
| Alabama 4,319,000 77,742 |
| Kentucky 3,908,000 70,344 |
| Colorado 3,893,000 70,074 |
| South Carolina 3,760,000 67,680 |
| Oklahoma 3,317,000 59,706 |
| Connecticut 3,270,000 58,860 |
| Oregon 3,243,000 58,374 |
| Iowa 2,852,000 51,336 |
| Mississippi 2,731,000 49,158 |
| Kansas 2,595,000 46,710 |
| Arkansas 2,523,000 45,414 |
| Utah 2,059,000 37,062 |
| West Virginia 1,816,000 32,688 |
| New Mexico 1,730,000 31,140 |
| Nevada 1,677,000 30,186 |
| Nebraska 1,657,000 29,826 |
| Maine 1,242,000 22,356 |
| Idaho 1,210,000 21,780 |
| Hawaii 1,187,000 21,366 |
| New Hampshire 1,173,000 21,114 |
| Rhode Island 987,000 17,766 |
| Montana 879,000 15,822 |
| South Dakota 738,000 13,284 |
| Delaware 732,000 13,176 |
| North Dakota 641,000 11,538 |
| Alaska 609,000 10,962 |
| Vermont 549,000 9,882 |
| District of Columbia 529,000 9,522 |
| Wyoming 480,000 8,640 |
SOURCE California Hepatitis C Coalition
CONTACT: Mary Odbert, 916-658-0144, or Kassy Perry, 916-296-8303, both for the California Hepatitis C Coalition/
991112
PR991107
Copyright © 1999 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .